CoChat

Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study

Hersant, Barbara, SidAhmed-Mezi, Mounia, Belkacemi, Yazid, Darmon, Franklin, Bastuji-Garin, Sylvie, Werkoff, Gabrielle, Bosc, Romain, Niddam, Jeremy, Hermeziu, Oana, La Padula, Simone, Meningaud, Jean Paul · 2018 · Menopause

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Objective: Approximately 50% to 70% of breast cancer survivors are affected by one or more symptoms of vulvovaginal atrophy (VVA). For those who cannot take hormone therapy, autologous platelet-rich plasma combined with hyaluronic acid (A-PRP-HA) may provide a new alternative therapy for the treatment of VVA in postmenopausal women with history of breast cancer. Methods: We enrolled 20 postmenopausal breast cancers survivors with VVA and a score of <15 on the Gloria Bachman Vaginal Health Index (VHI) comprised of five items including: vaginal pH, elasticity, fluid volume (secretions), epithelial integrity, and moisture. We administered intramucosal injections of A-PRP combined with HA (Regenkit) and performed clinical evaluations at 0, 1, 3, and 6 months. Primary endpoint: evaluation of vulvovaginal mucosa changes using the VHI; secondary endpoint: evaluation of dyspareunia and sexual dysfunction based on the Female Sexual Distress (FSD) score. Results: All participants (20 women) showed improvement in the clinical symptoms of vaginal dryness and dyspareunia. The VHI score showed a significant increase at 6 months, going from a total baseline score (pretreatment) of 10.7 ± 2.12 to 20.75 ± 4.8 ( P < 0.0001) at 6 months. Improvement in hydration and vaginal epithelial integrity was reported. A VHI score of > 15 showed a successful treatment outcome. The FSD score decreased significantly during the study, from a baseline score of 36.35 ± 2.53 pretreatment to 30.15 ± 2.47 6 months after treatment, representing improvement of 17% ( P < 0.0001, respectively). No adverse events were reported. Conclusions: The injection of A-PRP-HA appeared to be a promising method to improve the trophicity and hydration of vaginal mucosa for the treatment of VVA in postmenopausal breast cancer survivors with contraindications to hormone therapy.

Overview

Integrity signals

Registry

Crossref · 10.1097/gme.0000000000001122

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 2

  1. Guerid, 2013, Autologous keratinocyte suspension in platelet concentrate accelerates and enhances wound healing - a prospective randomized clinical trial on skin graft donor sites: platelet concentrate and keratinocytes on donor sites, Fibrogenesis Tissue Repair, 6, 8, 10.1186/1755-1536-6-8 · DOI
  2. Charles Runels, 2014, Ernest Debourbon and Lisbeth Roy, J Women's Health Care, 3, 4

Cited by

See all 86

Metadata

Authors
Hersant, B., SidAhmed-Mezi, M., Belkacemi, Y., Darmon, F., Bastuji-Garin, S., Werkoff, G., Bosc, R., Niddam, J., Hermeziu, O., La Padula, S., & Meningaud, J. P.
Affiliations
  • Centre Hospitalier Universitaire Henri-Mondor (FR)
  • Department of Maxillofacial and Plastic & Reconstructive Surgery, Henri Mondor University Hospital, Créteil, France
  • Henri Mondor Breast Center, Henri Mondor Hospital, Creteil, France
  • AP-HP, Hospital Henri Mondor, Department of Public Health and Clinical Research Unit (URC Mondor), Créteil cedex, France
Corresponding author
Hersant, Barbara
Venue
Menopause
Published
2018-10
Volume
25
Issue
10
Pages
1124-1130
ISSN
  • 1072-3714 (ISSN-L)
  • 1530-0374
OpenAlex
W2911861105
Cited by
86
References
38
Citations by year
2026: 7 · 2025: 14 · 2024: 11 · 2023: 14 · 2022: 16 · 2021: 9 · 2020: 8 · 2019: 4 · 2018: 1
FWCI
4.41
Type
journal article
Language
en
Open access
closed
Locations
  • Menopause The Journal of The North American Menopause Society (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
Keywords
vaginal atrophy, breast cancer survivors, autologous platelet-rich plasma, hyaluronic acid, postmenopausal women, vaginal dryness, dyspareunia, female sexual dysfunction, non-hormonal therapy
MeSH terms
Cancer Survivors, Adjuvants, Immunologic, Aged, Complementary Therapies, Analysis of Variance, Atrophy, Breast Neoplasms, Female, Follow-Up Studies, France, Hospitals, University, Humans, Hyaluronic Acid, Middle Aged, Pilot Projects, Prospective Studies, Sexual Dysfunction, Physiological, Vagina, Vulva, Treatment Outcome, Patient Satisfaction, Postmenopause, Regenerative Medicine, Platelet-Rich Plasma, Administration, Mucosal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study. https://app.cochat.ai/papers/10.1097/gme.0000000000001122
The paper
Hersant, B., SidAhmed-Mezi, M., Belkacemi, Y., Darmon, F., Bastuji-Garin, S., Werkoff, G., Bosc, R., Niddam, J., Hermeziu, O., La Padula, S., & Meningaud, J. P. (2018). Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study. Menopause. https://doi.org/10.1097/gme.0000000000001122

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.